EP0041019A3 - Products prepared from the thymic series factor or from its analogues and derivatives, process for preparation thereof, use of these products as medicines, radioactive tracers obtained from these products and use of these radioactive tracers in dosage processes - Google Patents

Products prepared from the thymic series factor or from its analogues and derivatives, process for preparation thereof, use of these products as medicines, radioactive tracers obtained from these products and use of these radioactive tracers in dosage processes Download PDF

Info

Publication number
EP0041019A3
EP0041019A3 EP81400807A EP81400807A EP0041019A3 EP 0041019 A3 EP0041019 A3 EP 0041019A3 EP 81400807 A EP81400807 A EP 81400807A EP 81400807 A EP81400807 A EP 81400807A EP 0041019 A3 EP0041019 A3 EP 0041019A3
Authority
EP
European Patent Office
Prior art keywords
products
radioactive tracers
thymic
analogues
medicines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP81400807A
Other languages
French (fr)
Other versions
EP0041019A2 (en
EP0041019B1 (en
Inventor
Jean-Francois Bach
Jean-Marie Pleau
Mireille Dardenne
Pierre Lefrancier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to AT81400807T priority Critical patent/ATE10089T1/en
Publication of EP0041019A2 publication Critical patent/EP0041019A2/en
Publication of EP0041019A3 publication Critical patent/EP0041019A3/en
Application granted granted Critical
Publication of EP0041019B1 publication Critical patent/EP0041019B1/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/062Serum thymic factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
EP19810400807 1980-05-22 1981-05-21 Products prepared from the thymic series factor or from its analogues and derivatives, process for preparation thereof, these products for use as medicines, radioactive tracers obtained from these products and use of these radioactive tracers in dosage processes Expired EP0041019B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT81400807T ATE10089T1 (en) 1980-05-22 1981-05-21 PREPARATIONS PREPARED FROM THYMIC SERIC FACTOR OR ITS ANALOGUES AND DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, SUCH PREPARATIONS FOR USE AS MEDICINAL PRODUCTS, ISOTOPE INDICATORS OBTAINED FROM SUCH PRODUCTS AND USE OF SUCH ISOTOPE INDICATORS IN DOSING METHODS.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8017027 1980-05-22
GB8017027 1980-05-22
GB8030507 1980-09-22
GB8030507 1980-09-22

Publications (3)

Publication Number Publication Date
EP0041019A2 EP0041019A2 (en) 1981-12-02
EP0041019A3 true EP0041019A3 (en) 1982-03-10
EP0041019B1 EP0041019B1 (en) 1984-10-31

Family

ID=26275622

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19810400807 Expired EP0041019B1 (en) 1980-05-22 1981-05-21 Products prepared from the thymic series factor or from its analogues and derivatives, process for preparation thereof, these products for use as medicines, radioactive tracers obtained from these products and use of these radioactive tracers in dosage processes

Country Status (8)

Country Link
EP (1) EP0041019B1 (en)
AU (1) AU553640B2 (en)
CA (1) CA1170991A (en)
DE (1) DE3166925D1 (en)
DK (1) DK221681A (en)
ES (2) ES502911A0 (en)
GR (1) GR75636B (en)
IE (1) IE51744B1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634682A (en) * 1982-11-30 1987-01-06 Sloan-Kettering Institute For Cancer Radioimmunoassays for the serum thymic factor (FTS)
CS256897B1 (en) * 1984-12-17 1988-04-15 Evzen Kasafirek Series thymic factor's analogue-type peptides
IT1188550B (en) * 1986-02-07 1988-01-14 Sclavo Spa SYNTHETIC PEPTIDE WITH INTERLEUKINA 1 HUMAN ACTIVITY
FR2830451B1 (en) * 2001-10-09 2004-04-30 Inst Nat Sante Rech Med USE OF THYMULIN-LIKE PEPTIDES (PAT) FOR THE MANUFACTURE OF PAIN MEDICATIONS
JP5296667B2 (en) 2006-03-20 2013-09-25 スミス アンド ネフュー インコーポレーテッド Acetabular cup assembly for multiple bearing elements
FR2930156B1 (en) * 2008-04-21 2011-10-28 Cll Pharma USE OF NONAPEPTIDE PAT IN THE TREATMENT OF AUTOIMMUNE DISEASES.
US20210060117A1 (en) * 2019-08-15 2021-03-04 Cytolyf Therapeutics Llc Zinc activated thymulin and methods of preparation and administration

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Biological Abstracts, Vol. 71, No. 7, page 4778, Ref. 45560, Bioscience Information Service Columbus, Ohio (US) R.K. CHANDRA et al.: "Serum thymic Factor Activity in Deficiencies of Calories, Zinc. Vitamin A and Pyridoxine" & Clin. Exp. Immunol. 42(2): 332-335, 1980 * en entier * *
Comptes Rendus de l'Academie des Sciences de Paris, Serie III, t. 292, Fasc. 13, 30 Mars 1981, Paris (FR) M. DARDENNE et al.: "Role du Zinc et Dhautres Metaux dans l'Activite Bologique du FTS (Thymuline)", pages 793-796 * en entier * *

Also Published As

Publication number Publication date
EP0041019A2 (en) 1981-12-02
GR75636B (en) 1984-08-02
ES518298A0 (en) 1984-12-16
ES8306022A1 (en) 1983-05-01
IE51744B1 (en) 1987-03-18
IE811135L (en) 1981-11-22
CA1170991A (en) 1984-07-17
ES502911A0 (en) 1983-05-01
EP0041019B1 (en) 1984-10-31
ES8501628A1 (en) 1984-12-16
AU553640B2 (en) 1986-07-24
DE3166925D1 (en) 1984-12-06
DK221681A (en) 1981-11-23
AU7090581A (en) 1981-11-26

Similar Documents

Publication Publication Date Title
IL62082A0 (en) -lactam derivatives,process for the preparation thereof and pharmaceutical compositions containing them
DE3263633D1 (en) Imidazodiazepines, process for their preparation and pharmaceutical compositions containing them
IL71310A0 (en) Benzimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL64665A0 (en) Quinazoline derivatives,their preparation and pharmaceutical compositions containing them
DE3267673D1 (en) Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same
DE3171234D1 (en) Pyrimidone derivatives, processes for their preparation and pharmaceutical derivatives containing them
PT75815B (en) Process for preparing morphinane derivatives and pharmaceutical compositions containing the same
DE3160805D1 (en) Antiallergic imidodisulfamides, pharmaceutical compositions containing them and process for their preparation
IL58238A (en) Aldehyde-treated allergen-containing substances,process for their preparation and pharmaceutical compositions comprising the same
DE2966142D1 (en) Quinolein-3-carboxylic acid derivatives, process for their preparation, their use in medicines and pharmaceutical compositions containing them
EP0034349A3 (en) Novel pyridinecarboxamide derivatives, a process for the preparation thereof, the use of said derivatives and a pharmaceutical composition containing same
IL65247A0 (en) Amido-amino acids,process for their preparation and pharmaceutical compositions containing them
DE3161238D1 (en) 20-deoxyrosaramicin derivatives, process for their preparation and pharmaceutical compositions containing them
PT73061B (en) Process for the preparation of new derivatives of taurina and its pharmaceutical use
DE3167664D1 (en) Pyrazoloindazole derivatives, process for preparing the same, and pharmaceutical composition containing the same
DE3166925D1 (en) Products prepared from the thymic series factor or from its analogues and derivatives, process for preparation thereof, these products for use as medicines, radioactive tracers obtained from these products and use of these radioactive tracers in dosage processes
DE3277838D1 (en) Thiazolylurea derivatives, process for their preparation, and medicinal composition containing same
DE3262919D1 (en) Imidazoline derivatives, process for the preparation thereof, pharmaceutical compositions containing them and their use
DE3271383D1 (en) Ascochlorin derivatives; process for preparing the same and pharmaceutical composition containing the same
IL65810A0 (en) Substituted tryptamine derivatives of thienyloxypropanolamines,process for their preparation,pharmaceutical products based on these compounds and the use of these products
GB2073747B (en) Triazolopyridinone compounds process for the preparation thereof and pharmaceutical preparations containing them
PT76870B (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
DE3165733D1 (en) Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them
IL62747A0 (en) 2-guanidinothiazole derivatives,process for the preparation thereof and pharmaceutical compositions comprising the same
IL64123A (en) Biphenylyloxypropoxypyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LU NL SE

17P Request for examination filed

Effective date: 19820326

ITF It: translation for a ep patent filed

Owner name: SOCIETA' ITALIANA BREVETTI S.P.A.

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

REF Corresponds to:

Ref document number: 10089

Country of ref document: AT

Date of ref document: 19841115

Kind code of ref document: T

REF Corresponds to:

Ref document number: 3166925

Country of ref document: DE

Date of ref document: 19841206

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
EPTA Lu: last paid annual fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19920519

Year of fee payment: 12

Ref country code: GB

Payment date: 19920519

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 19920525

Year of fee payment: 12

ITTA It: last paid annual fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19920531

Year of fee payment: 12

Ref country code: LU

Payment date: 19920531

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19920612

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19920622

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19920629

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19930521

Ref country code: GB

Effective date: 19930521

Ref country code: AT

Effective date: 19930521

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19930522

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19930527

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Effective date: 19930531

Ref country code: CH

Effective date: 19930531

Ref country code: BE

Effective date: 19930531

BERE Be: lapsed

Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M

Effective date: 19930531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19931201

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19930521

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19940201

EUG Se: european patent has lapsed

Ref document number: 81400807.4

Effective date: 19931210

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Effective date: 19950131

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST